Provided by Tiger Trade Technology Pte. Ltd.

Stoke Therapeutics, Inc.

24.74
+0.79003.30%
Post-market: 24.740.00000.00%19:30 EDT
Volume:918.96K
Turnover:22.76M
Market Cap:1.60B
PE:-7.42
High:25.20
Open:23.98
Low:23.79
Close:23.95
52wk High:40.22
52wk Low:20.32
Shares:64.53M
Float Shares:45.61M
Volume Ratio:1.08
T/O Rate:2.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3325
EPS(LYR):-0.1163
ROE:-61.10%
ROA:-35.87%
PB:4.62
PE(LYR):-212.79

Loading ...

Feb 17, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 24, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2022

Major Issues Report

8-K - Current report
Dec 17, 2021

Major Issues Report

8-K - Current report
Dec 03, 2021

Major Issues Report

8-K - Current report
Nov 08, 2021

Major Issues Report

8-K - Current report
Nov 08, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 21, 2021

Major Issues Report

8-K - Current report
Sep 09, 2021

Major Issues Report

8-K - Current report
Aug 10, 2021

Major Issues Report

8-K - Current report
Aug 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 30, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 29, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 09, 2021

Major Issues Report

8-K - Current report
May 14, 2021

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

Major Issues Report

8-K - Current report